| Synonyms: | |
| Status: | Approved (2023) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 49DXG3M5ZW |
| InChI Key | BALLNEJQLSTPIO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H19N3O5 |
| Molecular Weight | 393.4 |
| AlogP | 3.85 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 95.71 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Vascular endothelial growth factor receptor inhibitor | PubMed |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 1 | |
| fms related receptor tyrosine kinase 4 | |
| kinase insert domain receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1194506-26-7 |
| ChEMBL | CHEMBL4303214 |
| FDA SRS | 49DXG3M5ZW |
| Guide to Pharmacology | 9428 |
| PubChem | 44480399 |
| SureChEMBL | SCHEMBL947183 |
| ZINC | ZINC000114898570 |